Health Care & Life Sciences » Pharmaceuticals | Kyongbo Pharmaceutical Co. Ltd.

Kyongbo Pharmaceutical Co. Ltd.

Kyongbo Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW469.72
Market Cap
KRW231.9 B
Shares Outstanding
23.91 M
Public Float
8.73 M

Profile

Address
174 Sirok-ro
Asan SC 31501
Korea, Republic Of
Employees -
Website http://www.kbpharma.co.kr
Updated 07/08/2019
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, anticancer active pharmaceutical ingredients, inhalation anesthetic, cefaclor capsule and cefaclor dried syrup. The company was founded on March 31, 1987 and is headquartered in Asan, South Korea.

Financials

View All
Created with Highcharts 5.0.14Kyongbo Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.18 02518 0258 6368 63626 11026 11012 70612 70617 96317 96313 11613 11620132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Kyongbo Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.162 218162 218169 781169 781178 033178 033186 726186 726191 661191 661201 344201 344201320142015201620172018050k100k150k200k250k

Tae-Won Kang
President, Chief Executive Officer & Director
Seung-Ho Choi
Director & Vice President